AGTC and Bionic Sight Partner to Restore Vision Using Optogenetic Therapy – Genetic Engineering & Biotechnology News (press release)
|
AGTC and Bionic Sight Partner to Restore Vision Using Optogenetic Therapy
Genetic Engineering & Biotechnology News (press release) Applied Genetic Technologies (AGTC) and Bionic Sight are teaming up to develop a new form of optogenetic therapy that can restore vision in patients who have visual deficiencies or are blind as a result of retinal disease. The technology will combine … AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual …Yahoo Finance |
Xconomy |
Armed with $16M, Cue Biopharma Aims for Selective Immunotherapy
Xconomy Cue is now unveiling its immunotherapy approach, along with $16.4 million in new capital, led by MDB Capital Group. The investment follows $10 million in seed funding the company raised after it was founded in 2015. The technology underlying Cue’s … Cue Biopharma Debuts With $26 Million in Invested Capital to Develop Next-Generation Biologics to Selectively …Yahoo Finance |
|
AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual …
Yahoo Finance “AGTC is excited to combine our expertise in gene therapy and ophthalmology with Bionic Sight’s transformative device that incorporates the retina’s neural code to improve the lives of patients with retinal disorders,” said Sue Washer, President and … |
|
AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual …
Yahoo Finance “AGTC is excited to combine our expertise in gene therapy and ophthalmology with Bionic Sight’s transformative device that incorporates the retina’s neural code to improve the lives of patients with retinal disorders,” said Sue Washer, President and … |
TrendinTech |
Pioneering Stem Cell Technique Promise Muscle Regeneration Without Cancer Risk
TrendinTech A new revolutionary stem cell technique is being used to treat those suffering from damaged muscles without the cancer risk that was previously present. This was the first time that researchers had successfully implanted synthetic stem cardiac cells … UW spinoff wins grant to advance stem cell researchWisconsin State Farmer Stem Cell Market to Project Decent Growth Globally by 2024 | Hexa ResearchMedgadget (blog) Stem Cell Research: Scientists Demonstrate How To Create Stem Cells From Skin CellsCounsel & Heal Satellite PR News (press release) –Military Technologies all 12 news articles » |
Nikkei Asian Review |
Following Trump won’t cheer up industry
Nikkei Asian Review Noriyuki Yanagawa, a University of Tokyo professor, predicts that U.S. industries will find themselves in a state of suspended animation during the next four years. Trump will stick to his “America first” trade policy and come down hard on importers he … |
|
Stempeutics receives European Process Patent for stem cell drug Stempeucel
Hindu Business Line Stempeutics Research, an advanced clinical stage biotech company, today announced that the European Patent Office (EPO) has granted a process patent for its novel stem cell-based drug Stempeucel. “We have received European Process Patent for our … |